Metro Healthcare Indonesia Tbk. vs Niramas Utama Tbk. — how do they compare? Metro Healthcare Indonesia Tbk. trades at Rp426 (market cap 14.23T, 106.3K 24h volume), while Niramas Utama Tbk. trades at Rp635 (market cap 848.22B, 10.75M 24h volume). The key difference: Metro Healthcare Indonesia Tbk. is far larger — about 16.8× Niramas Utama Tbk.'s market cap, and Niramas Utama Tbk. is more actively traded (10.75M versus 106.3K). Which is the better fit depends on your goals.
| CARE | JELI | |
|---|---|---|
Market Cap | 14.23T | 848.22B |
Volume | 106.3K | 10.75M |
Lot | 1.06K | 107.48K |
Turnover | 45.42M | 6.9B |
Average Price | 427.26 | 642.24 |
Value | 45.42M | 6.9B |
Indicative Equilibrium Price | 426 | 635 |
Indicative Equilibrium Volume | 25 | 6.4K |
Trailing returns across standard periods
Latest headlines on both assets
PT Metro Healthcare Indonesia Tbk (the “Company”) was established under the name PT Aruna Anjaya Perkasa, based on Notarial Deed No. 67 dated October 07, 2015 of Humberg Lie, S.H., S.E., M.Kn notary in Jakarta. The Company started its commercial operations in 2016 .
Read more on CARE →PT. Niramas Utama Tbk. (the Company) formerly PT Nata Sari Raya was established based on Notarial Deed No. 86 dated 22 November 1990, by Notary Samsul Hadi, S.H. The Company started its commercial operations in 1994. The parent entity and the ultimate parent entity of the Company are PT Niramas Utama International and PT Supra Sentral Investama
Read more on JELI →